Role of the prostaglandin E2 receptor subtype EP4 in ischemic brain injury

被引：0
|
作者：
Kojima, Fumiaki [1 ]
Ri, Akimasa [1 ]
Yuhki, Koh-ichi [1 ]
Suzuki, Yasuhiro [1 ]
Kashiwagi, Hitoshi [1 ]
Narumiya, Shuh [2 ]
Ushikubi, Fumitaka [1 ]
机构：
[1] Asahikawa Med Coll, Dept Pharmacol, Asahikawa, Hokkaido 0788510, Japan
[2] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068501, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2010年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：79P / 79P
页数：1
相关论文
共 50 条
  • [1] Role of EP4 prostaglandin E2 receptor in the ischemic liver
    Kuzumoto, Y
    Sho, M
    Ikeda, N
    Mizuno, T
    Hamada, K
    Akashi, S
    Tsurui, Y
    Kashizuka, H
    Nomi, T
    Kanehiro, H
    Nakajima, Y
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 422 - 424
  • [2] Vasorelaxation induced by prostaglandin E2 in human pulmonary vein:: role of the EP4 receptor subtype
    Foudi, N.
    Kotelevets, L.
    Louedec, L.
    Leseche, G.
    Henin, D.
    Chastre, E.
    Norel, X.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (08) : 1631 - 1639
  • [3] ROLE OF PROSTAGLANDIN E2 RECEPTOR EP4 IN NEPHROTOXIC SERUM NEPHRITIS
    Aringer, Ida
    Kirsch, Alexander H.
    Artinger, Katharina
    Schabhuettl, Corinna
    Jandl, Katharina
    Kozina, Andrijana
    Eller, Philipp
    Rosenkranz, Alexander R.
    Heinemann, Akos
    Eller, Kathrin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [4] Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4
    Kanno, Takayasu
    Nakagawa, Naoki
    Aonuma, Tatsuya
    Kawabe, Jun-ichi
    Yuhki, Koh-ichi
    Takehara, Naofumi
    Hasebe, Naoyuki
    Ushikubi, Fumitaka
    HEART AND VESSELS, 2023, 38 (04) : 606 - 613
  • [5] Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4
    Takayasu Kanno
    Naoki Nakagawa
    Tatsuya Aonuma
    Jun-ichi Kawabe
    Koh-ichi Yuhki
    Naofumi Takehara
    Naoyuki Hasebe
    Fumitaka Ushikubi
    Heart and Vessels, 2023, 38 : 606 - 613
  • [6] Prostaglandin E2 suppresses renal fibrosis via its receptor subtype EP4
    Nakagawa, N
    Fujino, T
    Yuhki, K
    Akiyoshi, H
    Hasebe, N
    Kikuchi, K
    Narumiya, S
    Ushikubi, F
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 259P - 259P
  • [7] Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype
    Castleberry, TA
    Lu, BH
    Smock, SL
    Owen, TA
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2001, 65 (04): : 167 - 187
  • [8] Differential regulation of prostaglandin E2 receptor subtypes, EP4/EP2 in a rat model of ischemic injury and tolerance
    Choi, JS
    Kim, HY
    Lee, MY
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 33 - 33
  • [9] Prostaglandin E2 and Its Receptor Subtype EP4 Are Involved in Ankylosing Spondylitis Disease Progression
    Srinath, Archita
    Guggino, Giuliana
    Sari, Ismail
    Zeng, Fanxing
    Ciccia, Francesco
    Haroon, Nigil
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] 3D HOMOLOGY MODEL OF THE HUMAN PROSTAGLANDIN E2 RECEPTOR EP4 SUBTYPE
    Margan, Daniela
    Borota, Ana
    Mracec, Maria
    Mracec, Mircea
    REVUE ROUMAINE DE CHIMIE, 2012, 57 (01) : 39 - 44
12345